Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties
•RTFs inhibit LPS-induced inflammation in macrophages.•RTFs decrease pro-inflammatory factors production.•RTFs increase anti-inflammatory cytokines secretion.•RTFs block TLR4/MD-2 mediated pathway.•RTFs reduce JNK phosphorylation and NF-κB activity. Radix Tetrastigmae (RT) has immunomodulatory activ...
Saved in:
Published in | Cytokine (Philadelphia, Pa.) Vol. 84; pp. 29 - 36 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.08.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •RTFs inhibit LPS-induced inflammation in macrophages.•RTFs decrease pro-inflammatory factors production.•RTFs increase anti-inflammatory cytokines secretion.•RTFs block TLR4/MD-2 mediated pathway.•RTFs reduce JNK phosphorylation and NF-κB activity.
Radix Tetrastigmae (RT) has immunomodulatory activity, particularly on inflammation and the flavonoids from RT (RTFs) are one of the main components. In this study, we detected the anti-inflammation potential of RTFs in LPS-induced RAW264.7 cells and tried to uncover the underlying mechanism. Results demonstrated that RTFs (10–160μg/ml) treatment significantly decreased LPS-induced production of pro-inflammatory mediators, including NO, IL-1β, TNF-α, IL-6, IL-12p40, sTNF-R1 and increased anti-inflammatory cytokine IL-10 expression in macrophages in a dose-dependent manner. Molecular research showed the up-regulated expression of TLR4, MD-2, MyD88 and TLR4/MD-2 complex induced by LPS were attenuated after RTFs treatment. Furthermore, phosphorylation and activity of JNK and NF-κB, two important downstream signaling molecules of TLR4/MD-2 pathway, were also changed along with TLR4/MD-2 complex. But no significant phosphorylation was observed on p38 and ERK. In conclusion, RTFs contribute to the regulation of LPS-induced inflammatory response in RAW264.7 cells through TLR4/MD-2 mediated NF-κB and JNK pathway. It may be a potential choice for the treatment of inflammation diseases. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1043-4666 1096-0023 |
DOI: | 10.1016/j.cyto.2015.08.003 |